Endpoint definition
↥| Name | DRUGADVERS_OSTEOPO |
|---|---|
| Long name | Drug-induced osteoporosis |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| Name | DRUGADVERS_OSTEOPO |
|---|---|
| Long name | Drug-induced osteoporosis |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 124 | 84 | 40 |
| Unadjusted prevalence (%) | 0.06 | 0.07 | 0.04 |
| Mean age at first event (years) | 57.69 | 57.51 | 58.06 |
| Case fatality at 5-years (%) | 4.03 | 0.00 | 12.50 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | 2.0 | 2.0 |
| Recurrence at 6 months (%) | 43.55 | 47.62 | 35.00 |
before Drug-induced osteoporosis
after Drug-induced osteoporosis
Loading survival analyses plot…
Loading survival analyses table…